Paul Surdez brings more than 25 years of investor relations and corporate communications leadership to Ionetix. His career spans multiple global public healthcare companies, including Catalent, LabCorp, and Covance, where he counseled the C-Suite on public disclosures, guidance, capital allocation, corporate governance, stakeholder communications, and M&A activity. He has been recognized numerous times in institutional investor surveys as a top investor relations officer. Paul holds an M.B.A. and B.S. from Rutgers Business School.